ACHN

Achillion Pharmaceuticals, Inc. News Headlines

$13.21
*  
0.455
3.57%
Get ACHN Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading ACHN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Regulus To See Further Declines
11/19/2014 12:21:00 PM - Seeking Alpha


Regulus To See Further Declines
11/19/2014 10:30:00 AM - Seeking Alpha


Regulus To See Further Declines
11/19/2014 10:30:00 AM - SeekingAlpha


Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
11/18/2014 1:00:00 PM - Investopedia


5 Momentum Stocks Currently on the Move with More Potential Upside
11/13/2014 12:34:00 PM - TheStreet


Will Achillion Pharmaceuticals (ACHN) Continue to Surge Higher? - Tale of the Tape
11/13/2014 7:25:51 AM - Zacks.com


Achillion Pharmaceuticals: Still Bullish, But Taking Profits
11/12/2014 5:06:00 PM - Seeking Alpha


Achillion Pharmaceuticals (ACHN) Stock Rises on Positive Hepatitis C Drug Results
11/12/2014 11:57:00 AM - TheStreet


This Tiny Biotech Is Piggybacking on Gilead Sciences, Inc.'s Success
11/12/2014 8:43:04 AM - Motley Fool


Achillion Jumps on Encouraging Data on its HCV Candidate - Analyst Blog
11/11/2014 5:10:00 PM - Zacks.com


Why Is Gilead Always Holding The Ace? A Prediction Of The Future HCV Market And What Analysts Aren't Talking About
11/11/2014 11:13:00 AM - Seeking Alpha


Gilead presents Harvoni data
11/11/2014 11:03:00 AM - Seeking Alpha


Gilead presents data from three HCV drug combo studies
11/11/2014 9:05:00 AM - Seeking Alpha


Achillion Pharmaceuticals (ACHN) Looks Strong: Stock Up 27.1% - Tale of the Tape
11/11/2014 8:44:00 AM - Zacks.com


Pre-Market Most Active for Nov 11, 2014 : PAGP, BABA, ZNGA, VOD, ACHN, VALE, TKR, UL, TVIX, PBR, YHOO, CMCSA
11/11/2014 8:39:48 AM - NASDAQ.com News


Closing Update: Stocks Eke Out Gains as Transports Fuel Another Higher Close
11/10/2014 4:20:15 PM - MT Newswires


Mid-Afternoon Market Update: Sothebys Climbs On Upbeat Revenue; GoPro Shares Dip
11/10/2014 3:13:27 PM - Benzinga


Monday's ETF Movers: XBI, GDXJ
11/10/2014 2:41:27 PM - BNK Invest


Mid-Day Market Update: Gogo Shares Slide On Wider Loss; Achillion Pharmaceuticals Shares Jump
11/10/2014 1:05:18 PM - Benzinga


Stocks Quietly Grind Higher, But Stifled By Lack of Fresh Catalysts
11/10/2014 12:42:26 PM - MT Newswires


Mid-Morning Market Update: Markets Edge Higher; Dean Foods Posts Narrower-Than-Expected Loss
11/10/2014 11:11:01 AM - Benzinga


Pre-Market Most Active for Nov 10, 2014 : BABA, ALU, MTU, GILD, GPRO, PBR, QQQ, NVO, ACHN, TVIX, NMR, AAPL
11/10/2014 8:39:57 AM - NASDAQ.com News


Achillion's Phase 2 Trial Of ACH-3102, Sofosbuvir Meets Primary Objective
11/8/2014 9:30:00 AM - RTT News


Why Achillion Pharmaceuticals, Inc. Stock Launched 18% Higher in October
11/6/2014 9:40:03 AM - Motley Fool


Achillion Pharmaceuticals Slumps: ACHN Plunges 15.6% in Session - Tale of the Tape
11/5/2014 8:34:00 AM - Zacks.com